NO20060360L - Nye 8-azabisyklo [3.2.1] oktanderivater og deres anvendelse som monoaminneurotransmittergjenopptaksinhibitorer - Google Patents
Nye 8-azabisyklo [3.2.1] oktanderivater og deres anvendelse som monoaminneurotransmittergjenopptaksinhibitorerInfo
- Publication number
- NO20060360L NO20060360L NO20060360A NO20060360A NO20060360L NO 20060360 L NO20060360 L NO 20060360L NO 20060360 A NO20060360 A NO 20060360A NO 20060360 A NO20060360 A NO 20060360A NO 20060360 L NO20060360 L NO 20060360L
- Authority
- NO
- Norway
- Prior art keywords
- azabicyclo
- reuptake inhibitors
- new
- monoamine neurotransmitter
- neurotransmitter reuptake
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Denne oppfinnelsen vedrører nye 8-azabisyklo[3,2,l]oktanderivater som kan anvendes som monoaminnevrotransmittergjenopptaksinhibitorer. Ved andre aspekter vedrører oppfinnelsen anvendelsen av disse forbindelsene i en fremgangsmåte for terapi og farmasøytiske preparater som omfatter forbindelsene ifølge oppfinnelsen.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300939 | 2003-06-24 | ||
DKPA200301487 | 2003-10-09 | ||
DKPA200400228 | 2004-02-13 | ||
PCT/EP2004/051167 WO2004113334A1 (en) | 2003-06-24 | 2004-06-18 | Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060360L true NO20060360L (no) | 2006-03-24 |
Family
ID=36754881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060360A NO20060360L (no) | 2003-06-24 | 2006-01-23 | Nye 8-azabisyklo [3.2.1] oktanderivater og deres anvendelse som monoaminneurotransmittergjenopptaksinhibitorer |
Country Status (18)
Country | Link |
---|---|
US (3) | US7407970B2 (no) |
EP (1) | EP1638965A1 (no) |
JP (1) | JP2009513491A (no) |
KR (1) | KR20060030482A (no) |
CN (1) | CN100368409C (no) |
AR (1) | AR044883A1 (no) |
AU (1) | AU2004249441B2 (no) |
BR (1) | BRPI0411608A (no) |
CA (1) | CA2530023A1 (no) |
CO (1) | CO5630004A2 (no) |
HK (1) | HK1089157A1 (no) |
IL (1) | IL171990A0 (no) |
IS (1) | IS8212A (no) |
NO (1) | NO20060360L (no) |
RU (1) | RU2344136C2 (no) |
TW (1) | TW200510404A (no) |
UA (1) | UA82517C2 (no) |
WO (1) | WO2004113334A1 (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA82517C2 (uk) * | 2003-06-24 | 2008-04-25 | Ньюросерч А/С | Нові похідні 8-аза-біцикло[3.2.1]октану та їх застосування як інгібіторів ресорбції моноамінових медіаторів |
US20050171079A1 (en) * | 2004-02-04 | 2005-08-04 | Schrimpf Michael R. | Amino-substituted tricyclic derivatives and methods of use |
US7365193B2 (en) | 2004-02-04 | 2008-04-29 | Abbott Laboratories | Amino-substituted tricyclic derivatives and methods of use |
CN101812056A (zh) * | 2004-06-18 | 2010-08-25 | 神经研究公司 | 作为单胺神经递质再摄取抑制剂的新颖烷基取代的哌啶衍生物 |
EP1838705A2 (en) | 2005-01-13 | 2007-10-03 | Neurosearch A/S | 3,8-substituted 8-aza-bicyclo [3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
TW200716627A (en) | 2005-06-08 | 2007-05-01 | Neurosearch As | Novel compounds |
AU2006256738A1 (en) * | 2005-06-08 | 2006-12-14 | Neurosearch A/S | 3 -aryloxy- 8 -aza-bicyclo (3.2.1.) oct- 6- ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
TW200745101A (en) | 2005-09-30 | 2007-12-16 | Organon Nv | 9-Azabicyclo[3.3.1]nonane derivatives |
US7868017B2 (en) | 2005-09-30 | 2011-01-11 | N.V. Organon | 9-azabicyclo[3.3.1]nonane derivatives |
EP1779851A1 (en) * | 2005-10-31 | 2007-05-02 | Boehringer Ingelheim Pharma GmbH & Co.KG | Treatment of diabetes |
TW200804367A (en) * | 2005-11-11 | 2008-01-16 | Neurosearch As | Novel compounds |
US7605170B2 (en) | 2005-12-01 | 2009-10-20 | N.V. Organon | 8-azabicyclo[3.2.1]octane derivatives |
TW200806662A (en) * | 2005-12-01 | 2008-02-01 | Organon Nv | 8-azabicyclo[3.2.1]octane derivatives |
ATE529423T1 (de) | 2006-05-19 | 2011-11-15 | Abbott Lab | Cns-aktivierte kondensierte bi- und heterocyclisch substituierte azabicyklische alkanderivate |
TW200904815A (en) | 2007-05-09 | 2009-02-01 | Neurosearch As | Novel compounds |
DK2074120T3 (da) | 2007-10-25 | 2010-06-14 | Exelixis Inc | Tropan-forbindelser |
BRPI0907991A2 (pt) * | 2008-03-05 | 2015-10-20 | Neurosearch As | composto, composição farmacêutica, e, uso do composto |
WO2014005274A1 (zh) * | 2012-07-03 | 2014-01-09 | 海南卫康制药(潜山)有限公司 | 多取代的8-氮杂环【3.2.1】辛烷化合物 |
US10118927B2 (en) | 2012-12-27 | 2018-11-06 | Purdue Pharma L.P. | Substituted piperidin-4-amino-type compounds and uses thereof |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2640829A (en) * | 1950-11-10 | 1953-06-02 | Smith Kline French Lab | Isoquinolyl heterocyclic ethers |
GB969518A (en) * | 1961-04-27 | 1964-09-09 | Koninklijke Pharma Fab Nv | Tetrahydrodibenzocyclo-octene derivatives |
GB1008645A (en) | 1963-08-06 | 1965-11-03 | Koninklijke Pharma Fab Nv | Dibenzocycloheptane derivatives |
GB1164555A (en) * | 1966-09-20 | 1969-09-17 | Chinoin Gyogyszer Es Vegyeszet | New Tropine Derivatives |
US3655675A (en) * | 1968-09-09 | 1972-04-11 | Sterling Drug Inc | N-(n-heteryl)-acylanilides |
US3657253A (en) * | 1970-08-31 | 1972-04-18 | Robins Co Inc A H | 3-aryloxy-8-carbamoylnortropanes |
FR2476088A2 (fr) | 1979-01-16 | 1981-08-21 | Delalande Sa | Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique |
IL61642A0 (en) | 1979-12-20 | 1981-01-30 | Beecham Group Ltd | Aniline derivatives,their preparation and pharmalceutical compositions containing them |
DE3268378D1 (en) | 1981-06-17 | 1986-02-20 | Beecham Group Plc | Alkylthio derivatives of azabicyclobenzamides, their preparation and pharmaceutical compositions |
JPS6070183A (ja) * | 1983-09-28 | 1985-04-20 | C Uyemura & Co Ltd | 化学銅めっき方法 |
ZA848275B (en) * | 1983-12-28 | 1985-08-28 | Degussa | New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring |
CA1307790C (en) * | 1987-08-04 | 1992-09-22 | Ian Anthony Cliffe | Ethers |
GB8718445D0 (en) * | 1987-08-04 | 1987-09-09 | Wyeth John & Brother Ltd | Pyridyl-ethers |
US4861889A (en) | 1988-03-14 | 1989-08-29 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(2,3,4,5,6-pentafluorophenoxy)-8-azabicyclo[3.2.1]octanes |
JP3087763B2 (ja) * | 1990-11-30 | 2000-09-11 | 三井化学株式会社 | 新規な複素環式化合物およびそれを含有する医薬組成物 |
US5710168A (en) * | 1991-10-23 | 1998-01-20 | Pfizer Inc. | 2-piperidino-1-alkanol derivatives as neuroprotective agents |
US5498610A (en) * | 1992-11-06 | 1996-03-12 | Pfizer Inc. | Neuroprotective indolone and related derivatives |
EP0777652B1 (en) * | 1994-08-18 | 2003-06-25 | Pfizer Inc. | Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives |
US5852037A (en) * | 1995-11-13 | 1998-12-22 | Eli Lilly And Company | Method for treating anxiety |
KR100446571B1 (ko) | 1996-02-22 | 2004-11-03 | 뉴로서치 에이/에스 | 트로판-유도체,이의제조방법및이를포함하는약제학적조성물 |
DE19629652A1 (de) * | 1996-03-06 | 1998-01-29 | Thomae Gmbh Dr K | 4-Amino-pyrimidin-Derivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
US6632823B1 (en) * | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
US6248752B1 (en) | 1998-02-27 | 2001-06-19 | Charles Duane Smith | Azabicyclooctane compositions and methods for enhancing chemotherapy |
WO2000027790A1 (en) * | 1998-11-11 | 2000-05-18 | Smithkline Beecham P.L.C. | Mutilin compounds |
JP2003523941A (ja) * | 1999-05-21 | 2003-08-12 | ファイザー・プロダクツ・インク | Nos阻害剤のための新規医薬組合せ |
AU2001249250A1 (en) | 2000-03-29 | 2001-10-08 | Research Triangle Institute | Selective ligands for the delta opioid receptor |
CA2364178C (en) * | 2000-12-05 | 2006-01-10 | Yasuhiro Katsu | N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
US20040106643A1 (en) | 2001-05-23 | 2004-06-03 | Gouliaev Alex Haarh | Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
MXPA05000757A (es) | 2002-07-18 | 2005-04-19 | Pfizer Prod Inc | Derivados de piperidina biciclicos como antagonistas del receptor de quimioquina ccr1. |
UA82517C2 (uk) * | 2003-06-24 | 2008-04-25 | Ньюросерч А/С | Нові похідні 8-аза-біцикло[3.2.1]октану та їх застосування як інгібіторів ресорбції моноамінових медіаторів |
-
2004
- 2004-06-18 UA UAA200510857A patent/UA82517C2/uk unknown
- 2004-06-18 CN CNB2004800155755A patent/CN100368409C/zh not_active Expired - Fee Related
- 2004-06-18 JP JP2006516168A patent/JP2009513491A/ja active Pending
- 2004-06-18 BR BRPI0411608-9A patent/BRPI0411608A/pt not_active IP Right Cessation
- 2004-06-18 KR KR1020057024770A patent/KR20060030482A/ko not_active Application Discontinuation
- 2004-06-18 AU AU2004249441A patent/AU2004249441B2/en not_active Ceased
- 2004-06-18 US US10/561,417 patent/US7407970B2/en active Active
- 2004-06-18 CA CA002530023A patent/CA2530023A1/en not_active Abandoned
- 2004-06-18 EP EP04741837A patent/EP1638965A1/en not_active Withdrawn
- 2004-06-18 RU RU2005138591/04A patent/RU2344136C2/ru not_active IP Right Cessation
- 2004-06-18 WO PCT/EP2004/051167 patent/WO2004113334A1/en active Application Filing
- 2004-06-21 TW TW093117906A patent/TW200510404A/zh unknown
- 2004-06-23 AR ARP040102198A patent/AR044883A1/es unknown
-
2005
- 2005-11-16 IL IL171990A patent/IL171990A0/en unknown
- 2005-12-16 CO CO05126920A patent/CO5630004A2/es not_active Application Discontinuation
- 2005-12-30 IS IS8212A patent/IS8212A/is unknown
-
2006
- 2006-01-23 NO NO20060360A patent/NO20060360L/no not_active Application Discontinuation
- 2006-08-25 HK HK06109422A patent/HK1089157A1/xx not_active IP Right Cessation
-
2008
- 2008-07-01 US US12/216,213 patent/US7888358B2/en not_active Expired - Fee Related
-
2011
- 2011-01-14 US US13/007,172 patent/US20110112139A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
UA82517C2 (uk) | 2008-04-25 |
EP1638965A1 (en) | 2006-03-29 |
CO5630004A2 (es) | 2006-04-28 |
KR20060030482A (ko) | 2006-04-10 |
AU2004249441A1 (en) | 2004-12-29 |
US7888358B2 (en) | 2011-02-15 |
CA2530023A1 (en) | 2004-12-29 |
US20080269229A1 (en) | 2008-10-30 |
IS8212A (is) | 2005-12-30 |
JP2009513491A (ja) | 2009-04-02 |
WO2004113334A1 (en) | 2004-12-29 |
US20060142331A1 (en) | 2006-06-29 |
CN1798745A (zh) | 2006-07-05 |
RU2344136C2 (ru) | 2009-01-20 |
RU2005138591A (ru) | 2006-07-27 |
BRPI0411608A (pt) | 2006-08-08 |
US20110112139A1 (en) | 2011-05-12 |
TW200510404A (en) | 2005-03-16 |
HK1089157A1 (en) | 2006-11-24 |
US7407970B2 (en) | 2008-08-05 |
AU2004249441B2 (en) | 2009-11-12 |
CN100368409C (zh) | 2008-02-13 |
AR044883A1 (es) | 2005-10-05 |
IL171990A0 (en) | 2011-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060360L (no) | Nye 8-azabisyklo [3.2.1] oktanderivater og deres anvendelse som monoaminneurotransmittergjenopptaksinhibitorer | |
NO20073628L (no) | Pyridoner som er nyttige som inhibitorer av kinaser | |
NO20053470L (no) | Triazolopyridaziner som proteinkinase-inhibitorer | |
NO20083918L (no) | Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser | |
NO20054359L (no) | Cykliske protein tyrosin kinase inhibitorer | |
NO20052888L (no) | Diamintriazoler anvendelige som inhibitorer av proteinkinaser | |
NO20084435L (no) | C-MET proteinkinaseinhibitorer | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
NO20052595L (no) | Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser. | |
NO20073140L (no) | Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser | |
NO20051100L (no) | Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer | |
NO20045677L (no) | Inhibitorer av JAK- og CDK2-proteinkinaser | |
NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
NO20072567L (no) | Triazoler nyttige som proteinkinase-inhibitorer | |
NO20055624L (no) | Tropanderivater og deres anvendelse som Ace-inhibitorer | |
WO2005123679A3 (en) | Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
EA200800374A1 (ru) | 1,4-дигидропиридин-конденсированные гетероциклы, способы их получения, применение и содержащие их композиции | |
WO2004113297A3 (en) | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
NO20084186L (no) | Nye aminer | |
NO20076448L (no) | Novel piperidine carboxylic acid amide derivatives | |
NO20083738L (no) | Sekundaere aminer som renininhibitorer | |
NO20073652L (no) | Enantiomerer av 3-heteroaryl-8H-8-azabisyklo(3.2.1)okt-2-en og deres anvendelse som monoaminnevrotransmitter-gjenopptaksinhibitorer | |
NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner | |
NO20084055L (no) | Nye primaere aminer | |
MX2009005916A (es) | Nuevos derivados de cromen-2-ona y su uso como inhibidores de la reabsorcion del neurotransmisor de monoamina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |